10-Q: Village Farms Q2 Profit Soars on Strategic Produce Sale

Village Farms International reports a significant Q2 2025 financial turnaround, driven by the strategic privatization of its produce segment and strong growth in its Canadian and Netherlands cannabis operations.

Summary

• Net income attributable to Village Farms International, Inc. shareholders for Q2 2025 was $26.497 million, a substantial improvement from a net loss of $23.549 million in Q2 2024.
• Consolidated sales for Q2 2025 increased by 12% to $59.899 million, up from $53.597 million in Q2 2024.
• Gross profit for Q2 2025 rose by 64% to $22.342 million, compared to $13.637 million in the prior year's quarter.
• Adjusted EBITDA for Q2 2025 was $13.260 million, a significant positive swing from $(3.559) million in Q2 2024.
• The company closed the privatization of certain assets and operations of its Fresh Produce segment on May 30, 2025, receiving $40 million in cash proceeds and a 37.9% equity ownership interest in Vanguard Food LP, resulting in a gain on sale of $19.985 million.
• Canadian Cannabis sales increased by 9% to $44.518 million, with international export sales surging by 690% year-over-year and 116% sequentially.
• Canadian Cannabis achieved a gross margin of 39% in Q2 2025, up from 26% in Q2 2024, and maintained a top-three overall market share position in Canada.
• Netherlands Cannabis (Leli Holland) commenced sales in Q1 2025, generating $2.483 million in Q2 2025 sales with a 58% gross margin and achieving 82.5% market penetration in participating coffeeshops.
• U.S. Cannabis sales decreased by 11% to $3.841 million, impacted by new CBD sales restrictions and competition from unregulated hemp-derived products.
• The Produce segment (continuing operations) reported sales of $8.574 million and a gross margin of 7% in Q2 2025, benefiting from favorable vendor settlements related to the Tomato Brown Rugose Fruit Virus (ToBRFV) infestation.

Sentiment

Score: 8

Explanation: The filing indicates a strong financial rebound and strategic repositioning, with significant improvements in net income and Adjusted EBITDA. Growth in key cannabis segments and successful debt refinancing are positive indicators, despite some challenges in the U.S. CBD market. The strategic divestiture of the produce segment allows for a sharper focus on higher-margin cannabis operations.

Positives

• Achieved a significant financial turnaround with net income of $26.497 million and positive Adjusted EBITDA of $13.260 million in Q2 2025.
• Successfully privatized a portion of the Produce segment, generating $40 million in cash and a strategic equity stake in Vanguard Food LP.
• Canadian Cannabis segment demonstrated strong performance with a 9% increase in sales and a substantial 690% rise in international export sales.
• Canadian Cannabis gross margin improved significantly to 39%, indicating enhanced profitability and efficiency.
• Refinanced syndicated Canadian Cannabis Term Loans, resulting in a lower variable interest rate (below 6.0%) and improved financial covenants.
• Netherlands Cannabis operations (Leli Holland) are ramping up effectively, showing strong profitability and cash flow generation with 82.5% market penetration.
• Regained compliance with the Nasdaq minimum closing bid price requirement.
• Remediated previously identified material weaknesses in internal control over financial reporting, strengthening financial processes.

Negatives

• U.S. Cannabis segment experienced an 11% decline in sales, attributed to new CBD sales restrictions in additional states and competition from unregulated hemp-derived products.
• The Canadian excise tax continues to be a significant cost, representing 37% of gross branded sales in Q2 2025.
• The Produce segment (continuing operations) still operates with a relatively low gross margin of 7% and reported a gross loss for the six months ended June 30, 2025.

Risks

• The company may fail to realize the expected benefits of privatizing certain assets and operations of its Produce Segment.
• Limited control over the new produce partnership (Vanguard Food LP) due to the company's minority interest, potentially leading to returns not proportional to risks or resources contributed.
• Potential non-performance, default, or bankruptcy of partners in the new produce venture.
• Uncertainty regarding the legality and regulatory status of cannabis in the United States.
• Risks related to obtaining additional financing on acceptable terms, including dependence on credit facilities and dilutive transactions.
• Variability of product pricing in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses.
• Inflationary effects on fuel prices, labor, and materials costs, and recessionary impacts on product demand.
• Elevated interest rates affecting borrowing costs.
• Foreign exchange exposure due to international operations.

Future Outlook

The company expects international expansion to enhance profitability and brand presence in emerging legal cannabis markets. Construction of the Leli Holland Phase II facility is on track to be operational in Q1 2026, expected to quintuple total annualized production capacity. Leli Holland plans to launch hash products during Q4. The application for a Texas medicinal marijuana license remains pending review. The company will convert an additional 550,000 sq. ft. of its Delta 2 greenhouse to cannabis production following the 2025 tomato crop.

Management Comments

• "As a result of the typically higher margins in international medical markets, we expect international expansion to enhance our profitability while expanding our brand and experience into emerging legal cannabis markets."
• "The Company now believes it has become one of the largest importers of medical cannabis to Europe."
• "The Company's application for a Texas medicinal marijuana license remains pending review by the Department of Public Services."
• "The expansion will be funded with existing cash on hand, and is expected to yield an incremental 40 metric tonnes of annualized cannabis production once completed."

Industry Context

The U.S. CBD market faces challenges due to new state-level restrictions and the proliferation of unregulated hemp-derived products, impacting the company's U.S. Cannabis segment. Conversely, the international medical cannabis markets are presenting significant growth opportunities, which the company is actively pursuing. The Canadian cannabis market continues to be affected by burdensome excise taxes.

Comparison to Industry Standards

• Canadian Cannabis segment is positioned as one of the top-five best-selling producers nationally and one of the few Canadian licensed producers with consistently strong operating results.
• Leli Holland holds one of only ten licenses to cultivate and distribute recreational cannabis legally in the Netherlands under the country's Closed Supply Chain Experiment program.
• Balanced Health is noted as one of the leading cannabinoid brands and e-commerce platforms in the United States.
• The company believes it has become one of the largest importers of medical cannabis to Europe, based on German government data and company estimates.

Management Changes

Corporate Governance

Legal Proceedings

• The company is engaged in legal proceedings in the ordinary course of business, none of which are currently believed to be material to the business.

Related Party Transactions

• Lease of the Rose office building from a company employee who also holds a minority interest in Rose.
• Salary and benefits paid to an employee related to a member of the company's executive management team.
• Entered into a Transition Services Agreement (TSA) with Vanguard Food LP and its subsidiaries to provide certain transitional services for specified fees.
• Entered into a multi-year Sales, Marketing & Distribution Agreement with Vanguard Produce Canada ULC, a Vanguard subsidiary, for the sale, marketing, and distribution of hydroponically grown tomatoes from VFCLP's British Columbia greenhouse facilities.

Stakeholder Impact

• Shareholders: Significant increase in net income and Adjusted EBITDA, strategic shift to focus on cannabis, potential for enhanced profitability from international markets, and risks associated with the new produce partnership.
• Customers: Continued supply of produce through the new Vanguard partnership, potential for new cannabis products (e.g., hash), and improved product quality (e.g., new windowed packaging for flower products).
• Creditors: Refinancing of Canadian Cannabis Term Loans with more favorable terms and lower interest rates, improving the company's debt profile.
• Employees: The Transition Services Agreement involves company employees providing services to the new produce entity on a transitional basis.

Next Steps

• Leli Holland Phase II facility in Groningen is expected to be operational in Q1 2026, quintupling production capacity.
• Leli Holland expects to launch hash products during Q4.
• The company is currently assessing the impact of the recently enacted One Big Beautiful Bill Act (OBBBA) on its financial statements.
• The application for a Texas medicinal marijuana license remains pending review by the Department of Public Services.
• The company will convert the remaining 550,000 sq. ft. of its Delta 2 greenhouse to cannabis production following the 2025 tomato crop.
• VFCLP will make best efforts to assist Vanguard in finding replacement acreage for Delta 2 produce prior to the start of the 2026 growing season.
• The parties will mutually agree and finalize subsequent crop mixes by October 15 for the upcoming calendar year crop.

Key Dates

Recommendation

The company demonstrated a strong financial turnaround in Q2 2025, driven by a strategic divestiture of its produce segment and robust growth in its Canadian and Netherlands cannabis operations. The significant increase in net income and Adjusted EBITDA, coupled with improved gross margins in key segments and favorable debt refinancing, indicates a positive trajectory. While the U.S. CBD market faces headwinds, the company's focus on higher-margin international cannabis markets and planned capacity expansion positions it for continued growth. The remediation of internal control weaknesses further strengthens investor confidence. The strategic shift and strong operational performance suggest a compelling investment opportunity.

Keywords

Village Farms, VFF, Cannabis, Produce, Greenhouse, SEC Filing, 10-Q, Financial Results, Q2 2025, Vanguard Food, Pure Sunfarms, Leli Holland, CBD, Agricultural, Strategic Shift, Financial Performance, Corporate Governance